Core Laboratories NV (CLB) Analysts | Reuters.com
Edition:
United States

Core Laboratories NV (CLB)

CLB on New York Consolidated

123.64USD
1 Jul 2016
Change (% chg)

$-0.25 (-0.20%)
Prev Close
$123.89
Open
$123.53
Day's High
$123.97
Day's Low
$122.83
Volume
6,322
Avg. Vol
591,410
52-wk High
$135.49
52-wk Low
$84.50

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 0.40 December 1 Jul 2016

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 3 3 3
(2) OUTPERFORM 6 5 5 6
(3) HOLD 6 6 6 5
(4) UNDERPERFORM 0 0 0 1
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.20 2.21 2.21 2.27

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-16 10 149.11 158.80 144.10 212.55
Quarter Ending Dec-16 10 153.81 173.00 145.80 219.92
Year Ending Dec-16 14 608.23 658.00 589.50 885.72
Year Ending Dec-17 15 692.51 773.00 614.60 970.97
Earnings (per share)
Quarter Ending Sep-16 16 0.40 0.47 0.34 1.04
Quarter Ending Dec-16 16 0.44 0.57 0.34 1.10
Year Ending Dec-16 17 1.61 2.14 1.41 4.09
Year Ending Dec-17 19 2.44 3.42 1.62 5.25
LT Growth Rate (%) 1 20.00 20.00 20.00 18.00

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-16 158.42 153.65 4.78 3.01
Quarter Ending Dec-15 178.84 182.72 3.88 2.17
Quarter Ending Sep-15 201.06 197.26 3.79 1.89
Quarter Ending Jun-15 194.39 203.89 9.50 4.89
Quarter Ending Mar-15 211.82 213.64 1.82 0.86
Earnings (per share)
Quarter Ending Mar-16 0.37 0.37 0.00 0.16
Quarter Ending Dec-15 0.65 0.65 0.00 0.00
Quarter Ending Sep-15 0.83 0.83 0.00 0.10
Quarter Ending Jun-15 0.77 0.82 0.05 6.49
Quarter Ending Mar-15 0.85 0.86 0.01 1.52

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-16 149.11 149.11 149.12 149.02 212.55
Quarter Ending Dec-16 153.81 154.31 154.57 154.96 219.92
Year Ending Dec-16 608.23 608.55 609.21 605.46 885.72
Year Ending Dec-17 692.51 690.78 689.86 691.24 970.97
Earnings (per share)
Quarter Ending Sep-16 0.40 0.40 0.40 0.40 1.04
Quarter Ending Dec-16 0.44 0.44 0.44 0.44 1.10
Year Ending Dec-16 1.61 1.61 1.61 1.60 4.09
Year Ending Dec-17 2.44 2.43 2.43 2.44 5.25

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-16 0 0 0 0
Quarter Ending Dec-16 0 1 0 1
Year Ending Dec-16 0 1 0 1
Year Ending Dec-17 1 0 2 0
Earnings
Quarter Ending Sep-16 1 0 2 0
Quarter Ending Dec-16 0 0 1 0
Year Ending Dec-16 0 0 1 0
Year Ending Dec-17 1 0 2 0

Analyst Research Reports

Report Title Price
Provider : New Constructs, LLC
$25.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : Stock Traders Daily
$20.00
Provider : ValuEngine, Inc.
$25.00
Provider : S&P Capital IQ – STARS Reports
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.